BioSequence Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

BioSequence General Information

Description

Manufacturer of precision medicine for the treatment of cancer and other genetic diseases. The company offers genomic biomarker tests designed to detect the molecular alterations of a specific tumor, predict resistance to treatments and identify the most effective therapeutic options as well offers molecular profiling, data interpretation services and clinical decision online tools, thereby enabling healthcare professionals to monitor patient's response to therapy in real-time.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Avenida Amado Granell Mesado nº75
  • Office 8B 46013
  • 46013 Valencia
  • Spain
+34 960
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
Corporate Office
  • Avenida Amado Granell Mesado nº75
  • Office 8B 46013
  • 46013 Valencia
  • Spain
+34 960

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSequence Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioSequence‘s full profile, request access.

Request a free trial

BioSequence Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioSequence FAQs

  • When was BioSequence founded?

    BioSequence was founded in 2012.

  • Where is BioSequence headquartered?

    BioSequence is headquartered in Valencia, Spain.

  • What is the size of BioSequence?

    BioSequence has 3 total employees.

  • What industry is BioSequence in?

    BioSequence’s primary industry is Drug Discovery.

  • Is BioSequence a private or public company?

    BioSequence is a Private company.

  • What is BioSequence’s current revenue?

    The current revenue for BioSequence is .

  • When was BioSequence acquired?

    BioSequence was acquired on 23-Feb-2017.

  • Who acquired BioSequence?

    BioSequence was acquired by OncoDNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process